top of page

The new specialty pharma of veterinary Medical Cannabis in Brazil

Cats and dogs domestic animals

Dedication to technical excellence and innovation of our medicines and their benefits and safety for our pets.

31975-site-vettiva-imagem1.jpg
Cats and dogs domestic animals

About Vettiva

veterinarians taking care of a dog doing an examination

We are a veterinary pharmaceutical company pioneering in R&D (Research & Development) of innovative cannabidiol-based therapies. We have over 20 years of experience in developing solutions for human healthcare and we bring all the rigor of execution and inspection in this area to the care of animals.

When we design our products and processes, we are constantly searching for more advanced technologies, from certifications of active ingredients, satisfactory results of clinical safety and efficacy tests, to product presentations, focused on therapeutic benefits and safety for animals.

The company was founded by veterinarian, PhD, scientist and entrepreneur Dr. Gabriela Cezar , CEO of Panarea Partners, a healthcare M&A advisory boutique and pioneer in global operations for clients such as Aché Farmacêutica, Biolab Sanus, Algenis SpA, AmoyDX, and Instituto d'Or de Pesquisa e Ensino (IDOR), among others. Dr. Gabriela spent many years of her career as a scientist and executive at Pfizer in the United States, where she led the External Research & Development Innovation division in Latin America and South Africa. In addition, she is also a co-founder and former CSO (Chief Scientific Officer) of Stemina Biomarker Discovery, a biotechnology company in the United States. Finally, she was a professor and researcher in the Department of Animal Sciences at the University of Wisconsin-Madison in Madison, WI.

Economist and businessman José Henrique Nunes Barreto, CEO of SteviaSoul and Director of SINDIFUMO, among other businesses, is co-founder of Vettiva and member of its Board of Directors.

31975-site-vettiva-imagem5.png

Timeline

2024

Forecast for Registration of the 1st Veterinary Medicine based on Cannabidiol.

Clinical Studies on Efficacy and Safety and Preparation of the Submission Dossier to the therapeutic candidate for MAPA.

2023

2021

Creation of Vettiva

The new specialty pharma of veterinary medical cannabis in Brazil.

Beginning of the pharmacological development of the cannabidiol-based innovative therapeutic candidate.

2018

2017

Panarea Transactions

Panarea Partners has a rich track record of successful transactions. 

Foundation of Panarea Partners

Panarea Partners, a boutique M&A Advisory company in healthcare and a pioneer in global operations for clients such as Aché Laboratórios Farmacêuticos and Biolab Sanus, among others, is a shareholder in Vettiva.

2016

Âncora 1
31975-site-vettiva-imagem3.png

Contact Us

Avenida Nove de Julho 4939, Suite 13
Itaim Bibi
CEP: 01407-200 São Paulo, SP

    Thanks

    black dog

    Science and everyday life cannot and should not be separated."

    Rosalind Fanklin
    (1920 – 1958)

    ©2022 by Vettiva

    bottom of page